Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px

Organisation › Details

EMA (European Medicines Agency)

https://www.ema.europa.eu

	Start	renamed
	Group	EU (govt)
	Predecessor	EMEA (European Medicines Agency)
	Industry	pharmaceutical

	Region	Amsterdam
	Country	Netherlands
	Street	6 Domenico Scarlattilaan
	City	1083 HS Amsterdam
	Tel	+31-88-7816000
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2024-09-25

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for EU (govt)

[1] Lumicks Technologies B.V.. (10/10/24). "Press Release: Dutch Life Science Tools [Company] Lumicks Secures €20 Million from European Investment Bank to Accelerate Drug Discovery for Cancer"....
[2] Sequentia Biotech S.L.. (9/27/24). "Press Release: Sequentia Biotech Secures €10 Million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research Applications". Barcelona....
[3] Pentixapharm Holding AG. (8/26/24). "Press Release: Pentixapharm AG Receives Orphan Drug Designation for its Radiodiagnostic Tracer PentixaFor in Marginal Zone Lymphoma by the European Medicines Agency". Berlin & Würzburg....
[4] Protembis GmbH. (7/30/24). "Press Release: German Medtech Protembis Gets €20 million EIB Backing for Technology to Protect Brain during Heart Treatment". Luxembourg & Aachen....
[5] Boehringer Ingelheim. (7/29/24). "Press Release: CHMP Adopts Positive Opinion Recommending Approval of New and Expanded Indications for Spevigo". Ingelheim & La Jolla, CA....
[6] Integra Therapeutics S.L.. (7/16/24). "Press Release: Integra Therapeutics to Receive up to €10.5 Million from European Commission for Its FiCAT Advanced Therapies Platform". Lausanne & San Francisco, CA....
[7] Biovance Capital Partners. (7/9/24). "Press Release: Biovance Capital Partners Announces First Closing of Its New Biotech Fund at €51 million". Lisbon....
[8] Nyxoah S.A.. (7/3/24). "Press Release: Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank". Mont-Saint-Guibert....
[9] Valneva S.E.. (7/1/24). "Press Release: Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain....
[10] Biovance Capital Partners. (5/16/24). "Press Release: Biovance Capital Is the First Ever Investment in a Portuguese Life Sciences VC Fund by the EIF"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

» top